Regeneron Pharmaceuticals | Omløpsmidler

Current Assets Endring Dato
AbbVie USD 33.22B 4.37B 2023-09
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Incyte USD 4.65B 242.74M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Kyowa Hakko Kirin JPY 581.36B 7.3B 2023-09
Moderna USD 10.32B 474M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Opthea USD 98.39M 55.31M 2023-06
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
United Therapeutics USD 3.55B 92.1M 2023-12
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Regeneron Pharmaceuticals Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.